UBS Group’s Eledon Pharmaceuticals ELDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
126,266
+103,041
| +444% | +$279K | ﹤0.01% | 5131 |
|
|
2025
Q1 | $78.7K | Sell |
23,225
-295,356
| -93% | -$1M | ﹤0.01% | 5958 |
|
|
2024
Q4 | $1.31M | Buy |
318,581
+318,577
| +7,964,425% | +$1.31M | ﹤0.01% | 4040 |
|
|
2024
Q3 | $10 | Sell |
4
-54,997
| -100% | -$137K | ﹤0.01% | 8138 |
|
|
2024
Q2 | $145K | Buy |
55,001
+54,997
| +1,374,925% | +$145K | ﹤0.01% | 4772 |
|
|
2024
Q1 | $8 | Sell |
4
-552
| -99% | -$1.1K | ﹤0.01% | 7945 |
|
|
2023
Q4 | $1K | Buy |
+556
| New | +$1K | ﹤0.01% | 7225 |
|
|
2023
Q3 | – | Sell |
-32
| Closed | -$44 | – | 8382 |
|
|
2023
Q2 | $44 | Sell |
32
-424
| -93% | -$583 | ﹤0.01% | 7531 |
|
|
2023
Q1 | $1.08K | Sell |
456
-3,536
| -89% | -$8.34K | ﹤0.01% | 7720 |
|
|
2022
Q4 | $9.1K | Buy |
3,992
+2,978
| +294% | +$6.79K | ﹤0.01% | 7501 |
|
|
2022
Q3 | $3K | Sell |
1,014
-3,624
| -78% | -$10.7K | ﹤0.01% | 8419 |
|
|
2022
Q2 | $11K | Buy |
+4,638
| New | +$11K | ﹤0.01% | 6758 |
|
|
2022
Q1 | – | Sell |
-3,638
| Closed | -$16K | – | 9267 |
|
|
2021
Q4 | $16K | Buy |
3,638
+3,583
| +6,515% | +$15.8K | ﹤0.01% | 7034 |
|
|
2021
Q3 | $0 | Hold |
55
| – | – | ﹤0.01% | 8451 |
|
|
2021
Q2 | $0 | Hold |
55
| – | – | ﹤0.01% | 8330 |
|
|
2021
Q1 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 7719 |
|
|
2020
Q4 | – | Sell |
-4,200
| Closed | -$4K | – | 7413 |
|
|
2020
Q3 | $4K | Buy |
+4,200
| New | +$4K | ﹤0.01% | 6517 |
|
|
2020
Q1 | – | Sell |
-3,715
| Closed | -$2K | – | 7044 |
|
|
2019
Q4 | $2K | Buy |
+3,715
| New | +$2K | ﹤0.01% | 6744 |
|
|
2019
Q3 | – | Sell |
-1,666
| Closed | -$2K | – | 7031 |
|
|
2019
Q2 | $2K | Buy |
+1,666
| New | +$2K | ﹤0.01% | 6732 |
|
|
2019
Q1 | – | Sell |
-1,061
| Closed | -$2K | – | 6908 |
|
|
2018
Q4 | $2K | Buy |
+1,061
| New | +$2K | ﹤0.01% | 6861 |
|
|
2018
Q2 | – | Sell |
-2,547
| Closed | -$13K | – | 7047 |
|
|
2018
Q1 | $13K | Sell |
2,547
-1,166
| -31% | -$5.95K | ﹤0.01% | 5828 |
|
|
2017
Q4 | $15K | Buy |
3,713
+256
| +7% | +$1.03K | ﹤0.01% | 5784 |
|
|
2017
Q3 | $18K | Buy |
3,457
+3,066
| +784% | +$16K | ﹤0.01% | 5621 |
|
|
2017
Q2 | $2K | Buy |
391
+181
| +86% | +$926 | ﹤0.01% | 6414 |
|
|
2017
Q1 | $0 | Sell |
210
-1,229
| -85% | – | ﹤0.01% | 6705 |
|
|
2016
Q4 | $1K | Buy |
1,439
+1,018
| +242% | +$707 | ﹤0.01% | 6617 |
|
|
2016
Q3 | $1K | Sell |
421
-74
| -15% | -$176 | ﹤0.01% | 6559 |
|
|
2016
Q2 | $3K | Buy |
+495
| New | +$3K | ﹤0.01% | 6407 |
|
|
2016
Q1 | – | Sell |
-1,241
| Closed | -$11K | – | 6733 |
|
|
2015
Q4 | $11K | Buy |
1,241
+293
| +31% | +$2.6K | ﹤0.01% | 5944 |
|
|
2015
Q3 | $10K | Buy |
948
+798
| +532% | +$8.42K | ﹤0.01% | 5917 |
|
|
2015
Q2 | $2K | Hold |
150
| – | – | ﹤0.01% | 6541 |
|
|
2015
Q1 | $2K | Sell |
150
-1,014
| -87% | -$13.5K | ﹤0.01% | 6432 |
|
|
2014
Q4 | $17K | Buy |
+1,164
| New | +$17K | ﹤0.01% | 5682 |
|